The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer
暂无分享,去创建一个
Norman Boyd | John L Hopper | Irene L Andrulis | Julia A Knight | Argyrios Ziogas | Hoda Anton-Culver | Susan L Neuhausen | Alice S Whittemore | Melissa C Southey | Jeanne C Beck | A. Whittemore | N. Boyd | D. Seminara | J. Hopper | E. John | M. Southey | S. Buys | A. Ziogas | H. Anton-Culver | D. West | I. Andrulis | J. Knight | S. Neuhausen | F. O'Malley | V. Venne | R. Santella | M. Daly | D. Venter | R. Senie | Daniela Seminara | Regina M Santella | Mary B Daly | Esther M John | Dee W West | Ruby T Senie | Saundra S Buys | Frances P O'Malley | Vickie L Venne | Deon J Venter | J. Beck
[1] Alfred A. Boyd,et al. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 , 1996, Nature Genetics.
[2] B. Ponder. Genetic predisposition to cancer. , 1991, British Journal of Cancer.
[3] Thomas M. Mack,et al. Heritable breast cancer in twins , 2002, British Journal of Cancer.
[4] A. Whittemore,et al. Comparison of DNA‐ and RNA‐Based Methods for Detection of Truncating BRCA1 Mutations , 2002, Human mutation.
[5] S. Seal,et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. , 1999, Journal of the National Cancer Institute.
[6] C. Turnbull,et al. Genetic predisposition to cancer. , 2005, Clinical medicine.
[7] J. Carlin,et al. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. , 1992, American journal of epidemiology.
[8] I. Andrulis,et al. Ethnicity, but not cancer family history, is related to response to a population-based mailed questionnaire. , 2004, Annals of epidemiology.
[9] N. Boyd,et al. Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies. , 2002, Annals of epidemiology.
[10] G. Giles,et al. Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort. , 1994, Asia Pacific journal of clinical nutrition.
[11] D. Seminara,et al. Participation in the cooperative family registry for breast cancer studies: issues of informed consent. , 2000, Journal of the National Cancer Institute.
[12] S. Friend,et al. Screening for germ line TP53 mutations in breast cancer patients. , 1992, Cancer research.
[13] D. Grabrick,et al. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. , 2000, JAMA.
[14] Sean V Tavtigian,et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] L. Le Marchand,et al. A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[16] J. Sambrook,et al. Dominant negative ATM mutations in breast cancer families. , 2002, Journal of the National Cancer Institute.
[17] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[18] E. John,et al. Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] L. Kolonel,et al. Validation of a quantitative diet history method in Hawaii. , 1991, American journal of epidemiology.
[20] G. Giles,et al. Regressive logistic and proportional hazards disease models for within‐family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer , 2003, Genetic epidemiology.
[21] J Halpern,et al. Multi-stage sampling in genetic epidemiology. , 1997, Statistics in medicine.
[22] L. Palmer,et al. Genomewide scans of complex human diseases: true linkage is hard to find. , 2001, American journal of human genetics.
[23] John L Hopper. Commentary: Case-control-family designs: a paradigm for future epidemiology research? , 2003, International journal of epidemiology.
[24] A. Whittemore,et al. Study design in genetic epidemiology: theoretical and practical considerations. , 1999, Journal of the National Cancer Institute. Monographs.
[25] N E Day,et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes , 2002, British Journal of Cancer.
[26] J. Peto,et al. High constant incidence in twins and other relatives of women with breast cancer , 2000, Nature Genetics.
[27] S. Seal,et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.
[28] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[29] Alice S Whittemore,et al. Logistic regression of family data from retrospective study designs , 2003, Genetic epidemiology.
[30] G. Giles,et al. Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] Ralph J. Greenspan,et al. The flexible genome , 2001, Nature Reviews Genetics.
[32] John S Witte,et al. Point: population stratification: a problem for case-control studies of candidate-gene associations? , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[33] O. Olopade,et al. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2 , 1999, The Lancet.
[34] Nazneen Rahman,et al. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002, Nature Genetics.
[35] Noreen Clancy,et al. Case Studies of Existing Human Tissue Repositories: "Best Practices" for a Biospecimen Resource for the Genomic and Proteomic Era , 2003 .